Published in Nat Rev Urol on October 18, 2011
Postoperative drainage does not prevent complications after robotic partial nephrectomy. World J Urol (2015) 0.77
Risk factors and management of urine leaks after partial nephrectomy. J Urol (2008) 2.30
Routine drain placement after partial nephrectomy is not always necessary. J Urol (2011) 1.61
Urinary fistulae after partial nephrectomy. BJU Int (2010) 1.22
Closed suction or penrose drainage after partial nephrectomy: does it matter? J Urol (2004) 0.96
Endoscopic retrieval of retained Jackson-Pratt drain. Urology (2001) 0.88
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer (2009) 3.12
Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol (2009) 2.55
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol (2011) 2.43
Identification of the retrotrigonal layer as a key anatomical landmark during robotically assisted radical prostatectomy. BJU Int (2006) 2.10
Phase one pilot study using magnetic resonance spectroscopy to predict the histology of radiofrequency-ablated renal tissue. Eur Urol (2008) 2.03
Perioperative outcomes in patients undergoing conventional laparoscopic versus laparoendoscopic single-site pyeloplasty. Urology (2009) 1.96
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol (2009) 1.92
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol (2009) 1.90
Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int (2011) 1.78
The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol (2009) 1.78
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol (2012) 1.65
Laparoendoscopic single-site surgery in urology: where have we been and where are we heading? Nat Clin Pract Urol (2008) 1.62
Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer (2010) 1.58
Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol (2012) 1.57
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol (2008) 1.54
Minimally invasive nephrectomy: the influence of laparoendoscopic single-site surgery on patient selection, outcomes, and morbidity. Urology (2010) 1.54
The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. J Endourol (2011) 1.53
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol (2009) 1.52
Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial. BJU Int (2013) 1.52
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. BJU Int (2011) 1.50
Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy. BJU Int (2007) 1.50
Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases. BJU Int (2012) 1.48
An obese body habitus does not preclude a minimally invasive partial nephrectomy. Can J Urol (2014) 1.48
Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int (2014) 1.45
Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma. Urology (2013) 1.44
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol (2010) 1.44
Impact of warm versus cold ischemia on renal function following partial nephrectomy. World J Urol (2014) 1.43
Variable prostate-specific antigen management patterns by nonurologist providers at a tertiary care medical center. Urology (2011) 1.41
Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol (2010) 1.40
Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol (2010) 1.26
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol (2012) 1.21
How physician and patient perceptions differ regarding medical management of stone disease. J Urol (2009) 1.17
Synchronous bilateral percutaneous nephrostolithotomy: analysis of clinical outcomes, cost and surgeon reimbursement. J Urol (2008) 1.13
Increasing body mass index negatively impacts outcomes following robotic radical prostatectomy. JSLS (2008) 1.11
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol (2012) 1.10
Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Urology (2006) 1.05
Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. BJU Int (2009) 1.05
Chronic kidney disease before and after partial nephrectomy. J Urol (2010) 1.05
Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? Urol Oncol (2008) 1.04
Residual fragments following ureteroscopic lithotripsy: incidence and predictors on postoperative computerized tomography. J Urol (2012) 1.03
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int (2008) 1.03
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int (2013) 1.00
Impact of body mass index on cost and clinical outcomes after percutaneous nephrostolithotomy. Urology (2008) 1.00
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int (2008) 0.99
Laparoscopic adrenalectomy for large adrenal masses. Curr Urol Rep (2008) 0.98
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol (2012) 0.96
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy. J Urol (2012) 0.95
Determinants of quality of life for patients with kidney stones. J Urol (2008) 0.95
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology (2008) 0.92
Complications during the initial experience with laparoendoscopic single-site pyeloplasty. BJU Int (2011) 0.92
High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol (2012) 0.91
Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma. J Manag Care Pharm (2011) 0.90
Current status of renal radiofrequency ablation. Curr Opin Urol (2009) 0.90
Predictive factors of recurrence and survival of upper tract urothelial carcinomas. World J Urol (2011) 0.88
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma. World J Urol (2012) 0.88
Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate. World J Urol (2014) 0.87
Feasibility of laparoscopic approach in management of xanthogranulomatous pyelonephritis. Urology (2006) 0.87
Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. Urol Oncol (2011) 0.86
General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol (2009) 0.86
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int (2011) 0.86
A delay in radical nephroureterectomy can lead to upstaging. BJU Int (2009) 0.85
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int (2009) 0.85
Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol (2011) 0.85
Management and prevention of renal ablative therapy complications. World J Urol (2010) 0.84
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol (2010) 0.84
Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma. Cancer (2014) 0.84
Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies. Urology (2005) 0.83
The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy. Can J Urol (2012) 0.83
Predictors of cost and clinical outcomes of percutaneous nephrostolithotomy. J Urol (2009) 0.83
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. J Urol (2012) 0.82
Ergonomics considerations of radical prostatectomy: physician perspective of open, laparoscopic, and robot-assisted techniques. J Endourol (2009) 0.82
Rationale and timing of perioperative chemotherapy for upper-tract urothelial carcinoma. Expert Rev Anticancer Ther (2014) 0.82
Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes. BJU Int (2013) 0.82
Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome. BJU Int (2009) 0.81
Bladder cancer following upper tract urothelial carcinoma. Expert Rev Anticancer Ther (2008) 0.81
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol (2011) 0.81
Retroperitoneal lymph node dissection after chemotherapy. BJU Int (2009) 0.81
Laparoendoscopic single-site pyeloplasty. Ther Adv Urol (2011) 0.79
Optical reflectance spectroscopy to differentiate benign from malignant renal tumors at surgery. Urology (2008) 0.79
Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects. Biomark Med (2008) 0.79
Renal tumor ablation is a function of patient selection and technique--not the ablation technology. Cancer (2008) 0.78
Predictors of survival in patients with disease recurrence after radical nephroureterectomy. BJU Int (2014) 0.78
Risk of cancer-specific mortality following recurrence after radical nephroureterectomy. Ann Surg Oncol (2012) 0.78
Current status of ablative techniques for small renal masses. Expert Rev Anticancer Ther (2011) 0.78
Does obesity impact the costs of partial and radical nephrectomy? J Urol (2008) 0.78
Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy? Int Braz J Urol (2013) 0.78
Critical analysis of 30 day complications following radical nephroureterectomy for upper tract urothelial carcinoma. Can J Urol (2014) 0.77
Cutaneous renocolic fistula associated with diverticulitis. Can J Urol (2008) 0.77
The role of lymphadenectomy for upper tract urothelial carcinoma. Nat Rev Urol (2011) 0.76
Re: Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review D. A. Kunkle, B. L. Egleston and R. G. Uzzo J Urol 2008; 179: 1227-1234. J Urol (2008) 0.76
Conservative nephron-sparing treatment of upper-tract tumors. Curr Urol Rep (2013) 0.76
Editorial Comment to renal pelvic villous adenoma presented with mucusuria: report of a case and literature review. Int J Urol (2012) 0.75
Small renal masses: is LESS partial nephrectomy feasible for most urologists? Nat Rev Urol (2013) 0.75
Editorial comment. Urology (2009) 0.75
Laparoscopic radical nephrectomy for renal masses 7 centimeters or larger. JSLS (2009) 0.75